Good Life Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $577K | Buy |
5,205
+476
| +10% | +$52.8K | 0.04% | 284 |
|
|
2025
Q1 | $530K | Sell |
4,729
-139
| -3% | -$15.6K | 0.04% | 288 |
|
|
2024
Q4 | $450K | Sell |
4,868
-6,748
| -58% | -$623K | 0.03% | 308 |
|
|
2024
Q3 | $974K | Buy |
11,616
+7,171
| +161% | +$601K | 0.06% | 225 |
|
|
2024
Q2 | $305K | Buy |
4,445
+442
| +11% | +$30.3K | 0.03% | 355 |
|
|
2024
Q1 | $293K | Buy |
4,003
+328
| +9% | +$24K | 0.03% | 353 |
|
|
2023
Q4 | $298K | Sell |
3,675
-429
| -10% | -$34.8K | 0.03% | 329 |
|
|
2023
Q3 | $308K | Sell |
4,104
-51
| -1% | -$3.82K | 0.04% | 307 |
|
|
2023
Q2 | $320K | Buy |
4,155
+1,257
| +43% | +$96.9K | 0.04% | 299 |
|
|
2023
Q1 | $240K | Buy |
2,898
+405
| +16% | +$33.6K | 0.03% | 332 |
|
|
2022
Q4 | $214K | Buy |
+2,493
| New | +$214K | 0.03% | 318 |
|
|
2020
Q3 | – | Sell |
-2,689
| Closed | -$206K | – | 258 |
|
|
2020
Q2 | $206K | Buy |
+2,689
| New | +$206K | 0.06% | 227 |
|
|
2019
Q1 | – | Sell |
-3,822
| Closed | -$239K | – | 248 |
|
|
2018
Q4 | $239K | Sell |
3,822
-196
| -5% | -$12.3K | 0.08% | 194 |
|
|
2018
Q3 | $307K | Buy |
4,018
+2
| +0% | +$153 | 0.09% | 170 |
|
|
2018
Q2 | $283K | Sell |
4,016
-179
| -4% | -$12.6K | 0.09% | 169 |
|
|
2018
Q1 | $306K | Sell |
4,195
-195
| -4% | -$14.2K | 0.1% | 148 |
|
|
2017
Q4 | $327K | Sell |
4,390
-9
| -0.2% | -$670 | 0.1% | 152 |
|
|
2017
Q3 | $357K | Buy |
4,399
+689
| +19% | +$55.9K | 0.14% | 123 |
|
|
2017
Q2 | $258K | Sell |
3,710
-77
| -2% | -$5.36K | 0.11% | 158 |
|
|
2017
Q1 | $252K | Buy |
+3,787
| New | +$252K | 0.12% | 157 |
|